Skip to Main Content

Advertisement

Skip Nav Destination

In vivo administration of recombinant granulocyte-macrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis.

J Immunol (1991) 146 (12): 4204–4208.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal